Structured Summary
Abstract
Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
7 entry terms
- Customized Drug
- Customized Drugs
- Designer Drug
- Drug, Customized
- Drug, Designer
- Drugs, Customized
- Drugs, Designer
MeSH Record
Aspects Covered
18 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, chemical synthesis, chemistry, classification, economics, history, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity.
MeSH Record
Indexing Annotation
coordinate with specific drug or chemical; do not confuse with DRUG DESIGN
MeSH Record
History Note
1989
MeSH Record
Previous Indexing
- Chemistry, Pharmaceutical (1984-1988)
- Street Drugs (1985-1988)
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. Designer Drugs. Medical Subject Headings (MeSH). 2026. Unique ID D015198. http://id.nlm.nih.gov/mesh/2026/D015198
- Designer Drugs. In: Wikipedia. https://en.wikipedia.org/wiki/Designer_drug
- Designer Drugs. In: Wikidata. https://www.wikidata.org/wiki/Q1200715